INS and Hypoglycemia: Although no differences in glucose and insulin outcomes were noted in the immediate perioperative period, obvious benefits of the FCL approach in terms of an increase in the time spent with sensor levels between 5.6 and 10.0 mmol/L without increasing the risk of hypoglycemia were observed in the postoperative period (details are provided in Table 1).